Mats Ferm

843 total citations
17 papers, 613 citations indexed

About

Mats Ferm is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mats Ferm has authored 17 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Mats Ferm's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Alzheimer's disease research and treatments (4 papers). Mats Ferm is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Alzheimer's disease research and treatments (4 papers). Mats Ferm collaborates with scholars based in Sweden, United States and United Kingdom. Mats Ferm's co-authors include Rolf Kiessling, Lars Klareskog, Kalle Söderström, Alvar Grönberg, Alex Karlsson‐Parra, J Iványi, Juraj Iványi, E Nilsson, Sandra Kleinau and John R. Ortaldo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mats Ferm

17 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mats Ferm Sweden	11	246	246	80	74	73	17	613
Motohiro Yukitake Japan	17	267 1.1×	162 0.7×	113 1.4×	66 0.9×	39 0.5×	44	672
Vera Lehmensiek Germany	15	212 0.9×	227 0.9×	251 3.1×	115 1.6×	84 1.2×	22	848
James A. Martiney United States	14	163 0.7×	241 1.0×	43 0.5×	43 0.6×	102 1.4×	17	772
Bharathi Vayuvegula United States	14	222 0.9×	378 1.5×	95 1.2×	58 0.8×	113 1.5×	28	873
Josephe A. Honorat Japan	11	285 1.2×	105 0.4×	129 1.6×	37 0.5×	37 0.5×	13	847
Robert Graham Quinton Leslie Denmark	12	122 0.5×	266 1.1×	69 0.9×	45 0.6×	30 0.4×	19	538
P. Ian Andrews United States	10	336 1.4×	92 0.4×	100 1.3×	27 0.4×	67 0.9×	15	931
Shigeru Araga Japan	13	134 0.5×	89 0.4×	56 0.7×	108 1.5×	33 0.5×	34	642
Scott M. Seki United States	13	243 1.0×	202 0.8×	35 0.4×	220 3.0×	56 0.8×	18	960
Swamy K. Polumuri United States	16	278 1.1×	361 1.5×	15 0.2×	84 1.1×	100 1.4×	20	735

Countries citing papers authored by Mats Ferm

Since Specialization

Citations

This map shows the geographic impact of Mats Ferm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Ferm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Ferm more than expected).

Fields of papers citing papers by Mats Ferm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Ferm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Ferm. The network helps show where Mats Ferm may publish in the future.

Co-authorship network of co-authors of Mats Ferm

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Ferm. A scholar is included among the top collaborators of Mats Ferm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Ferm. Mats Ferm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nordvall, Gunnar, Ping Yan, Lotta Agholme, et al.. (2025). γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice. Journal of Pharmacology and Experimental Therapeutics. 392(4). 103400–103400. 1 indexed citations

Finn, Anja, Kristina Ängeby Möller, Charlotte Gustafsson, et al.. (2014). Influence of model and matrix on cytokine profile in rat and human. Lara D. Veeken. 53(12). 2297–2305. 11 indexed citations

Ericsson‐Dahlstrand, Anders, Anders Juréus, Sylvia Simon, et al.. (2014). Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Proceedings of the National Academy of Sciences. 111(14). 5409–5414. 74 indexed citations

Huang, Yafei, Rachel Potter, Wendy Sigurdson, et al.. (2012). β-Amyloid Dynamics in Human Plasma. Archives of Neurology. 69(12). 1591–1591. 56 indexed citations

Huang, Yafei, Rachel Potter, Wendy Sigurdson, et al.. (2012). β-Amyloid Dynamics in Human Plasma. JAMA Neurology. 1–1. 1 indexed citations

Soares, Holly, William Z. Potter, Fred Immermann, et al.. (2011). P2‐070: Changes in plasma based biomarkers in Alzheimer's disease, mild cognitively impaired and aged matched normal controls from the ADNI cohort. Alzheimer s & Dementia. 7(4S_Part_10). 1 indexed citations

Franzén, Bo, Kerstin Nilsson, L. Andersson, et al.. (2010). Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. Journal of Proteomics. 73(6). 1117–1132. 118 indexed citations

Olsson, Tomas, Charlotte Edenius, Mats Ferm, et al.. (2002). Depletion of Vβ5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis. European Journal of Neurology. 9(2). 153–164. 14 indexed citations

Ferm, Mats, et al.. (1996). IFN-γ Treatment Increases Insulin Binding and MHC Class I Expression in Erythroleukemia Cells. Immunological Investigations. 25(1-2). 37–47. 7 indexed citations

10.

Petersson, Max, Alvar Grönberg, Rolf Kiessling, & Mats Ferm. (1995). Engagement of MHC Class I Proteins on Natural Killer Cells Inhibits their Killing Capacity. Scandinavian Journal of Immunology. 42(1). 34–38. 7 indexed citations

11.

Grönberg, Alvar, Eva Halapi, Mats Ferm, Max Petersson, & Manuel E. Patarroyo. (1993). Regulation of Lymphocyte Aggregation and Proliferation through Adhesion Molecule GD54 (ICAM-1). Cellular Immunology. 147(1). 12–24. 8 indexed citations

12.

Ferm, Mats, Kalle Söderström, Satish Jindal, et al.. (1992). Induction of human hsp60 expression in monocytic cell lines. International Immunology. 4(3). 305–311. 40 indexed citations

13.

Ferm, Mats & Alvar Grönberg. (1991). Human MHC Class I Antigens are Associated with a 90‐kDa Cell Surface Protein. Scandinavian Journal of Immunology. 34(2). 221–227. 10 indexed citations

14.

Kiessling, Rolf, Juraj Iványi, Mats Ferm, et al.. (1991). Role of hsp60 during Autoimmune and Bacterial Inflammation. Immunological Reviews. 121(1). 91–111. 83 indexed citations

15.

Karlsson‐Parra, Alex, Kalle Söderström, Mats Ferm, et al.. (1990). Presence of Human 65 kD Heat Shock Protein (hsp) in Inflamed Joints and Subcutaneous Nodules of RA Patients. Scandinavian Journal of Immunology. 31(3). 283–288. 111 indexed citations

16.

Ferm, Mats, et al.. (1989). Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells. Cellular Immunology. 118(1). 10–21. 24 indexed citations

17.

Grönberg, Alvar, Mats Ferm, Joanne Ng, Craig W. Reynolds, & John R. Ortaldo. (1988). IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.. The Journal of Immunology. 140(12). 4397–4402. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact